Exfoliative dermatitis
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
Red (burning) Skin Syndrome ― Erythema na ọnụ ọgụgụ dị n'ahụ dum bụ isi ihe mgbaàmà nke Exfoliative dermatitis.
References
Erythroderma bụ ọnọdụ akpụkpọ ahụ na-adịghị ahụkebe. Ọ bụ ezie na a naghị amakarị ihe kpatara ya, ọ nwere ike ịkpalite ya site na mmeghachi omume ọgwụ ma ọ bụ ọrịa kansa na-akpata. Otu ọrịa cancer na-ejikọta na exfoliative dermatitis bụ lymphoma T-cell akpụkpọ anụ, nke nwere ike ọ gaghị egosi mgbaàmà ruo ọnwa ma ọ bụ ọbụna afọ mgbe ọnọdụ akpụkpọ ahụ malitere. Ọtụtụ mgbe, a na-achọ ụlọ ọgwụ maka nyocha na ọgwụgwọ mbụ. Ndị ọrịa na-arịa ọrịa na-ebute ọgwụ n'ozuzu nwere ezigbo anya ogologo oge, ọ bụ ezie na ikpe na-enweghị ihe doro anya na-enwekarị usoro na-emegharị ugboro ugboro. Amụma maka ọrịa metụtara ọrịa kansa na-adaberekarị n'otú ọrịa kansa si aga n'ihu.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Ọ na-egosipụtakarị ọbara ọbara na flaking na-ekpuchi ihe karịrị 90% nke ahụ. Ọnọdụ a bụ akara a na-ahụ anya nke nsogbu ahụike dị iche iche dị ka psoriasis, eczema, ma ọ bụ nzaghachi nke ọgwụ ụfọdụ.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Ihe na-akpatakarị erythroderma bụ mmụba nke ọrịa akpụkpọ anụ, dị ka psoriasis, kọntaktị dermatitis, seborrheic dermatitis, lichen planus, pityriasis rubra pilaris ma ọ bụ mmeghachi omume ọgwụ, dị ka iji ọgwụ steroid eme ihe. Nrụpụta nke mbụ na-adị obere oge, a na-ahụkarị ya n'ihe gbasara lymphoma T-cell akpụkpọ anụ. N'ihi na ọ dị mkpa ịmata ọdịiche dị na ya na lymphoma T cell akpụkpọ anụ, a na-eme biopsy.